Prevention of Cardiac Dysfunction During Breast Cancer Therapy
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female|Heart Failure
Interventions: DRUG: Sacubitril/valsartan
Sponsor: Torbjorn Omland
Collaborators: University Hospital, Akershus|Oslo University Hospital|University Hospital of North Norway|St. Olavs Hospital|Helse Stavanger HF|Klinbeforsk|Norwegian Cancer Society|Novartis